Advancing regulatory science for medical countermeasure development

workshop summary

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Advancing regulatory science for medical coun ...
Theresa M. Wizemann
Not in Library

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

Buy this book

Last edited by ImportBot
November 16, 2011 | History

Advancing regulatory science for medical countermeasure development

workshop summary

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing regulatory science for medical countermeasure development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing regulatory science for medical countermeasure development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description.

Publish Date
Language
English
Pages
132

Buy this book

Edition Availability
Cover of: Advancing regulatory science for medical countermeasure development
Advancing regulatory science for medical countermeasure development: workshop summary
2011, Natlional Academies Press
in English

Add another edition?

Book Details


Edition Notes

Includes bibliographical references (p. 81-82).

Also available online in Open Book format via the National Academies Press home page.

Published in
Washington, D.C

Classifications

Library of Congress
RA645.5 .A287 2011, , RA645.5 .A38 2011

The Physical Object

Pagination
xviii, 132 p. :
Number of pages
132

ID Numbers

Open Library
OL25104223M
ISBN 10
0309214904
ISBN 13
9780309214902
LCCN
2011499600
OCLC/WorldCat
744284130, 754086593

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
August 2, 2020 Edited by ImportBot import existing book
November 16, 2011 Created by LC Bot import new book